BIOSERGEN HAS BEEN APPROVED FOR LISTING ON NASDAQ FIRST NORTH GROWTH MARKET STOCKHOLM.
Biosergen has been approved for listing on Nasdaq First North Growth Market. The first day of trading will be June 24, 2021. Biosergens shares will be traded under the short name “BIOSGN” with the ISIN code SE0016013460. The warrants of series TO1 will be traded under the short name “BIOSGN TO1” with the ISIN code SE0016013478. The Company’s shareholders and holders of warrants are not required to do anything in this connection. Bell ringing ceremony Biosergen invites those interested to participate online at the Nasdaq bell ringing ceremony from 8.30 on June 24, 2021. Please use